A detailed history of Advisor Net Financial, Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Advisor Net Financial, Inc holds 1,310 shares of IRWD stock, worth $4,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,310
Holding current value
$4,506
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$3.93 - $7.04 $5,148 - $9,222
1,310 New
1,310 $5,000
Q4 2023

Jan 19, 2024

BUY
$8.79 - $11.51 $167 - $218
19 New
19 $0
Q2 2023

Jul 14, 2023

SELL
$10.1 - $11.6 $30 - $34
-3 Reduced 11.54%
23 $0
Q1 2023

Apr 28, 2023

BUY
$10.37 - $12.56 $10 - $12
1 Added 4.0%
26 $0
Q4 2022

Jan 13, 2023

BUY
$9.9 - $12.43 $247 - $310
25 New
25 $0

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $527M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.